CD14/LPS receptor exhibits lectin-like properties

Innate Immunity

Volumn 3, Issue 6, 1996, Pages 471-480

  Cavaillon, J M ^a   Marie, C ^a   Caroff, M ^b   Ledur, A ^c   Godard, I ^b   Poulain, D ^c   Fitting, C ^a   Haeffner Cavaillon, N ^c  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958125664     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/096805199600300605     Document Type: Article

References (56)

1. Van Lenten B.J., Fogelman A.M., Seager J., Ribi E., Haberland M.E., Edwards P.A. Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J Immunol 1985; 134: 3718-3721.
2. Hampton R.Y., Golenbock D.T., Penman M., Krieger M., Raetz C.R.H. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 1991; 352: 342-344.
3. Wright S.D., Levin S.M., Jong M.T.C., Chad Z., Kabbash L.G. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J Exp Med 1989; 169: 175-183.
4. Lei M.G., Stimpson S.A., Morrison D.C. Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes. III. Binding specificity and characterization. J Immunol 1991; 147: 1925-1932.
5. Halling J.L., Hamill D.R., Lei M.G., Morrison D.C. Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations. Infect Immun 1992; 60:845-852.
6. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide and LPS binding protein. Science 1990; 249: 1431-1433.
7. Ferrero E., Jiao D., Tsuberi B.Z.et al.Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90: 2380-2384.
8. Haziot A., Ferrero E., Köntgen F.et al.Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407-414.
9. Lee J.D., Kato K., Tobias P.S., Kirkland T.N., Ulevitch R.J. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide and LPS binding protein. J Exp Med 1992; 175: 1697-1705.
10. Golenbock D.T., Liu Y., Milham F.H., Freeman W., Zoeller R.A. Surface expression of human CD 14 in Chinese hamster ovary fibroblasts impart macrophage-like responsiveness to bacterial endotoxin. J Biol Chem 1993; 268: 22055-22059.
11. Couturier C., Jahns G., Kazatchkine M.D., Haeffner-Cavaillon N. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-α by lipopolysaccharide-stimulated human monocytes. Eur J Immunol 1992; 22: 1461-1466.
12. Delud R.L., Fenton M.J., Savedra R.et al.CD14-mediated translocation of nuclear factor-κB induced by lipopolysaccharide does not require tyrosine kinase activity. J Biol Chem 1994; 269: 22253-22260.
13. Stefanova I., Corcoran M.L., Horak E.M., Wahls L.M., Bolen J.B., Horak I.D. Lipopolysaccharide induces activation of CD14-associated protein tyrosine kinase p53/561yn. J Biol Chem 1993; 268:20725-20728.
14. Larsen N.E., Sullivan R. Interaction between endotoxin and human monocytes: characteristics of the binding of 3H-labeled lipopolysaccharide and 51Cr-labeled lipid A before and after the induction of endotoxin tolerance. Proc Natl Acad Sci USA 1984; 81: 3491-3495.
15. Hampton R.Y., Golenbock D.T., Raetz C.R.H. Lipid A binding sites in membranes of macrophage tumor cells. J Biol Chem 1988; 263, 14802-14807.
16. Hara-Kuge S., Amano F., Nisjijima M., Akamatsu Y. Isolation of lipopolysaccharide resistant mutant with defective LPS binding of cultured macrophage-like cells. J Biol Chem 1990; 265: 6606-6610.
17. Golenbock D.T., Hampton R.Y., Raetz R.R.H., Wright S.D. Human phagocytes have multiple lipid A binding sites. Infect Immun 1990; 58: 4069-4075.
18. Warner S.J.C., Savage N., Mitchell D. Characteristics of lipopolysaccharide interaction with human peripheral blood monocytes. Biochem J 1985; 232: 379-383.
19. Parent J.B. Membrane receptors on rat hepatocytes for the inner core region of bacterial lipopolysaccharides. J Biol Chem 1990; 265: 3455-3461.
20. Couturier C., Haeffner-Cavaillon N., Caroff M., Kazatchkine M.D. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J Immunol 1991; 147: 1899-1904.
21. Haeffner-Cavaillon N., Chaby R., Cavaillon J-M., Szabo L. Lipopolysaccharide receptor on rabbit peritoneal macrophages. I. Binding characteristics. j Immunol 1982; 128: 1950-1954.
22. Haeffner-Cavaillon N., CavaillonJ-M., Etiévant M., Lebbar S., Szabo L. Specific binding of endotoxin to human monocytes and mouse macrophages: serum requirement. Cell Immunol 1985; 91:119-131.
23. CavaillonJ-M., Muñoz C., Fitting C., Couturier C., Haeffner-Cavaillon N. Signals involved in interleukin-1 production induced by endotoxins. In: Nowotny A., Spizer J.J., Ziegler E.J. (Eds) Cellular and Molecular Aspects of Endotoxin Reactions., Amsterdam: Elsevier, 1990; 257-267.
24. CavaillonJ-M., Haeffner-Cavaillon N. Structure Function relationship of core oligosaccharide. In: Morrison D.C., Ryan J.L. (Eds) Bacterial Endotoxic Lipopolysaccharides Vol. 1 Molecular Biochemistry and Cellular Biology of LPS. Baton Rouge: CRC Press, 1992; 205-224.
25. Cavaillon J-M., Fitting C., Hauttecoeur B., Haeffner-Cavaillon N. Inhibition by gangliosides of the specific binding of lipopolysaccharide to human monocytes prevents LPS-induced interleukin-1 production. Cell Immunol 1987; 106: 293-303.
26. Cavaillon J-M., Fitting C., Haeffner-Cavaillon N., Kirsch S.J., Warren H.S. Cytokine response by monocytes/macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun 1990; 58:2375-2382.
27. Haeffner-Cavaillon N., Cavaillon J-M. Involvement of the LPS receptor in the induction of interleukin-1 in human monocytes stimulated with endotoxins. Ann Inst Pasteur (Immunol) 1987; 138:473-477.
28. Espevik T., Otterlei M., Skjak-Braek G., Ryan L., Wright S.D., Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol 1993; 23: 255-261.
29. Otterlei M., Sundan A., Skjak-Braek G., Ryan L., Smidsrod O., Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor-α induction. Infect Immun 1993; 61: 1917-1925.
30. Weidemann B., Brade H., Rietschel E.et al.Soluble peptidoglycan-induced monokine production can be blocked by anti-CD 14 monoclonal antibodies and by lipid A partial structures. Infect lmmun 1994; 62: 4709-4715.
31. Soell M., Lett E., Holveck F., Schöller M., Wachsmann D., Klein J.P. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD 14 antigen and mannan binding protein inhibits TNFα release. J Immunol 1995; 154: 851-860.
32. Zhang Y., Doerfler M., Lee T.C., Guillemenin B., Rom W.N. Mechanisms of stimulation of interleukin-1 β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J Clin Invest 1993; 91: 2076-2083.
33. Kusunokin T., Hailman E., Juan T.X.C., Lichenstein H.S., Wright S.D. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med 1995; 182: 1673-1682.
34. Cleveland M.G., Gorham J.D., Murphy T.L., Tuomanen E., Murphy K.M. Lipoteichoic acid preparations of Gram positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996; 64: 1906-1912.
35. Caroff M., Tacken A., Szabo L. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the isolated lipid A fragment of the Bordetella pertussis endotoxin. Carbohydr Res 1988; 175: 273-282.
36. Bhattacharjee A.K., Jennings H.J., Kenny C.P. Structural elucidation of the 3-deoxy-D-manno-octulosonic acid containing meningococcal 29-e capsular polysaccharide antigen using carbon-13 nuclear magnetic resonance. Biochemistry 1978; 17: 645-651.
37. Altman E., Brisson J.R., Perry M.B. Structure of the capsular polysaccharide of Haemophilus pleuropneumoniae serotype 5. Eur JBiochem 1987; 170:185-192.
38. Trinel P.A., Borg-von-Zepelin M., Lepage G., Jouault T., Mackenzie D., Poulain D. Isolation and preliminary characterization of the 14- to 18-kilodalton Candida albicans antigens as a phospholipomannan containing β-1,2-linked oligomannosides. Infect Immun 1993; 61: 4398-4405.
39. Watson J., Riblet R. Genetic control of responses to bacterial lipolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipopolysaccharide. J Immunol 1975; 114: 1462-1468.
40. Skelly R., Munrenbeck P., Morrison D.C. Stimulation of T-independent antibody response by hapten-lipopolysaccharide without repeating polymeric structure. Infect Immun 1979; 23: 287-293.
41. Caroff M., Karibian D. Several uses for isobutyric acid-ammonium hydroxide solvent in endotoxin analysis. Appl Environ Microbiol 1990; 56: 1957-1959.
42. Caroff M., Cavaillon J-M., Fitting C., Haeffner-Cavaillon N. Inability of pyrogenic Bordetella pertussis purified lipid A to induce interleukin-1 release by human monocytes. Infect Immun 1986; 54:465-471.
43. Warren H.S., Amato S.F., Fitting C., Black K., Loiselle P., Pasternack M., Cavaillon J-M. Assessment of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide. J Exp Med 1993; 177: 89-97.
44. Cavaillon J-M., Pitton C., Fitting C. Endotoxin tolerance is not a LPS-specific phenomenon: partial mimicry with IL-1, IL-10 and TGFβ. J Endotoxin Res 1994; 1: 21-29.
45. Joto N., Akimoto T., Someya K., Tohgo A. Production of tumor necrosis factor induced by synthetic low-toxicity lipid A analog, DT-5461a is mediated by LPS receptor sites and tyrosine kinase-MAP kinase signaling pathway in murine macrophages. Cell Immunol 1995; 160: 1-7.
46. Kitchens R.L., Ulevitch R., Munford R.S. Lipopolysaccharide partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting uptake by a CD14-mediated pathway. J Exp Med 1992; 176: 485-494.
47. Fagan M.A., Liu Y., Stütz P., Vyplel H., Golenbock D.T. Acyclic analogue of lipid A stimulates TNFα and arachidonate release via a unique LPS-signaling pathway. J Immunol 1994; 153: 5230-5238.
48. Kirikae F., Kirikae T., Qureshi N., Takayama K., Morrison D.C., Nakano M. CD 14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect Immun 1995; 63: 486-497.
49. Golenbock D.T., Bach R.R., Lichenstein H., Juan T.S.C., Tadavarthy A., Moldow C.F. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med 1995; 125: 662-671.
50. Lebbar S., Cavaillon J-M., Caroff M.et al.Molecular requirement for interleukin-1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto 3 deoxyoctulosonate region. Eur J Immunol 1986; 16: 87-91.
51. Shnyra A., Lindberg A.A. Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro. Infect Immun 1995; 63: 865-873.
52. Dziarski R., Gupta D. Heparin, sulfated heparinoids, and lipoteichoic acids bind to the 70 kDa peptidoglycan/lipopolysaccharide receptor protein on lymphocytes. J Biol Chem 1994; 269: 2100-2110.
53. Katz S.S., Chen K., Doerfler M.E., Elsbach P., Weiss J. Potent CD14-mediated signalling of human leukocytes by Escherichia coli can be mediated by interaction of whole bacteria and host cells without extensive prior release of endotoxin. Infect Immun 1996; 64: 3592-3600.
54. Cavaillon J.-M., Fitting C., Caroff M., Haeffner-Cavaillon N. Dissociation of cell-associated interleukin-1 and IL-1 release induced by lipopolysaccharide and lipid A. Infect Immun 1989; 57:791-797.
55. Cavaillon J-M. Cytokines and macrophages. Biomed Pharmacother 1994; 48: 445-453.
56. Jahr T.G., Sundan A., Lichenstein H.S., Espevik T. Influence of CD 14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length. Scand J Immunol 1995; 42: 119-127.